101 related articles for article (PubMed ID: 30097375)
1. How Does European Mistletoe Survive Without Complex I?
da Fonseca-Pereira P; Silva WB; Araújo WL; Nunes-Nesi A
Trends Plant Sci; 2018 Oct; 23(10):847-850. PubMed ID: 30097375
[TBL] [Abstract][Full Text] [Related]
2. Absence of Complex I Is Associated with Diminished Respiratory Chain Function in European Mistletoe.
Maclean AE; Hertle AP; Ligas J; Bock R; Balk J; Meyer EH
Curr Biol; 2018 May; 28(10):1614-1619.e3. PubMed ID: 29731304
[TBL] [Abstract][Full Text] [Related]
3. Comparative mitogenomics indicates respiratory competence in parasitic Viscum despite loss of complex I and extreme sequence divergence, and reveals horizontal gene transfer and remarkable variation in genome size.
Skippington E; Barkman TJ; Rice DW; Palmer JD
BMC Plant Biol; 2017 Feb; 17(1):49. PubMed ID: 28222679
[TBL] [Abstract][Full Text] [Related]
4. Absence of Complex I Implicates Rearrangement of the Respiratory Chain in European Mistletoe.
Senkler J; Rugen N; Eubel H; Hegermann J; Braun HP
Curr Biol; 2018 May; 28(10):1606-1613.e4. PubMed ID: 29731306
[TBL] [Abstract][Full Text] [Related]
5. The gene space of European mistletoe (Viscum album).
Schröder L; Hohnjec N; Senkler M; Senkler J; Küster H; Braun HP
Plant J; 2022 Jan; 109(1):278-294. PubMed ID: 34713513
[TBL] [Abstract][Full Text] [Related]
6. Phytochemical profile and therapeutic potential of Viscum album L.
Nazaruk J; Orlikowski P
Nat Prod Res; 2016; 30(4):373-85. PubMed ID: 25813519
[TBL] [Abstract][Full Text] [Related]
7. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
8. Massive gene loss in mistletoe (Viscum, Viscaceae) mitochondria.
Petersen G; Cuenca A; Møller IM; Seberg O
Sci Rep; 2015 Dec; 5():17588. PubMed ID: 26625950
[TBL] [Abstract][Full Text] [Related]
9. Leaf-spot disease on European mistletoe (Viscum album) caused by Phaeobotryosphaeria visci: a potential candidate for biological control.
Varga I; Taller J; Baltazár T; Hyvönen J; Poczai P
Biotechnol Lett; 2012 Jun; 34(6):1059-65. PubMed ID: 22395478
[TBL] [Abstract][Full Text] [Related]
10. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
11. Crystal Structure of Mistletoe Lectin I (ML-I) from Viscum album in Complex with 4-N-Furfurylcytosine at 2.85 Å Resolution.
Ahmad MS; Rasheed S; Falke S; Khaliq B; Perbandt M; Choudhary MI; Markiewicz WT; Barciszewski J; Betzel C
Med Chem; 2018; 14(8):754-763. PubMed ID: 29792147
[TBL] [Abstract][Full Text] [Related]
12. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
Bar-Sela G; Gershony A; Haim N
Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
[TBL] [Abstract][Full Text] [Related]
13. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis.
Vergara-Barberán M; Lerma-García MJ; Nicoletti M; Simó-Alfonso EF; Herrero-Martínez JM; Fasoli E; Righetti PG
J Proteomics; 2017 Jul; 164():52-58. PubMed ID: 28571969
[TBL] [Abstract][Full Text] [Related]
14. Botany of European mistletoe (Viscum album L.).
Becker H
Oncology; 1986; 43 Suppl 1():2-7. PubMed ID: 3808574
[TBL] [Abstract][Full Text] [Related]
15. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
16. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of Viscum album L. subsp. album (European misletoe) leaf extracts in myocardial ischemia and reperfusion.
Suveren E; Baxter GF; Iskit AB; Turker AU
J Ethnopharmacol; 2017 Sep; 209():203-209. PubMed ID: 28689799
[TBL] [Abstract][Full Text] [Related]
18. Novel GHB-derived natural products from European mistletoe (Viscum album).
Amer B; Juvik OJ; Francis GW; Fossen T
Pharm Biol; 2013 Aug; 51(8):981-6. PubMed ID: 23734579
[TBL] [Abstract][Full Text] [Related]
19. Viscum Album in the Treatment of a Girl With Refractory Childhood Absence Epilepsy.
von Schoen-Angerer T; Madeleyn R; Kienle G; Kiene H; Vagedes J
J Child Neurol; 2015 Jul; 30(8):1048-52. PubMed ID: 25038133
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
